InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Josephson Neil, Directeur Médical. Director active across 1 companies, notably Zymeworks Inc.. Aggregated, 7 disclosures have been published. Total volume traded: €35k. The latest transaction was filed on 10 March 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
0729 shares0
Common Shares
SEC:0000899243-22-010794:0·
€17,6851,400 shares@ €12.63180.0009% mcap59.0% of flow
Common Shares
SEC:0000899243-22-001679·
Ideal exit: 4 Oct 2022 (T+270)
€17,6851,400 shares@ €12.63180.0009% mcap29.5% of flow
Common Shares
SEC:0000899243-22-001679:0·
Ideal exit: 4 Oct 2022 (T+270)
€80265 shares@ €12.33970.0000% mcap2.7% of flow
Common Shares
SEC:0000899243-22-001425·
€80265 shares@ €12.33970.0000% mcap1.3% of flow
Common Shares
SEC:0000899243-22-001425:0·
€11,497461 shares@ €24.93970.0006% mcap38.3% of flow
Common Shares
SEC:0000899243-21-027912·
€11,497461 shares@ €24.93970.0006% mcap19.2% of flow
Common Shares
SEC:0000899243-21-027912:0·
7 of 7 declarations
About Josephson Neil
Neil Josephson is the Chief Medical Officer at Zymeworks Inc. He is responsible for leading the company's medical and research initiatives. His expertise is crucial for the development of innovative therapeutic solutions at Zymeworks.
